Forbion Growth Opportunities Fund III Cooperatief U.A. bought BRVE
August 7, 2026 · Form 4 insider transaction
Forbion Growth Opportunities Fund III Cooperatief U.A. bought 1,920,000 shares of Braveheart Bio, Inc. at $18.00 per share, a transaction worth $34.56M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
Forbion Growth III Management B.V. ("Forbion Growth III Management") is the director of Forbion Growth Opportunities Fund III Cooperatief U.A. (the "Forbion Growth III") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Growth III. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.